Home › Cardiomyopathy › District of Columbia
Cardiomyopathy clinical trials in District of Columbia
7 studies for Cardiomyopathy are looking for participants at sites in District of Columbia.
Cities in District of Columbia
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
- Hope Center, Washington D.C.
RecruitingObservational studyHealthy volunteers welcome
Ages 1 to 100 · All sexes · Updated Oct 2, 2026 · NCT01143454TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
- Clinical Trial Site, Washington D.C.
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 16, 2026 · NCT07052903Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C.
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Children's National, Washington D.C.
RecruitingObservational study
All ages · All sexes · Updated Jul 28, 2026 · NCT07674758The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients
- Medstar Washington Hospital Center, Washington D.C.
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT05034432MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
- MedStar Washington Hospital Center - MedStar Heart and Vascular Institute, Washington D.C.
RecruitingPhase 3
Ages 18 to 90 · All sexes · Updated Mar 27, 2026 · NCT06128629Prospective Observational Study of the ICD in Sudden Cardiac Death Prevention
- Washington Hospital Center, Washington D.C.
RecruitingObservational study
Ages 18 to 85 · All sexes · Updated Jan 20, 2026 · NCT00733590From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.